Tenon Medical, Inc. (TNON)
NASDAQ: TNON · Real-Time Price · USD
2.530
-0.010 (-0.39%)
Nov 20, 2024, 4:00 PM EST - Market closed
Tenon Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 3.32 | 2.93 | 0.69 | 0.16 | 0.04 | 0.05 |
| Revenue Growth (YoY) | 38.30% | 323.73% | 331.87% | 265.13% | -18.31% | - |
| Cost of Revenue | 1.4 | 1.69 | 1.33 | 0.06 | 0.02 | 0.02 |
| Gross Profit | 1.92 | 1.24 | -0.64 | 0.11 | 0.03 | 0.04 |
| Selling, General & Admin | 12.93 | 13.81 | 14.68 | 4.85 | 0.34 | 0.2 |
| Research & Development | 2.73 | 3.16 | 2.83 | 1.72 | 0.22 | 0.37 |
| Operating Expenses | 15.65 | 16.97 | 17.51 | 6.57 | 0.56 | 0.57 |
| Operating Income | -13.73 | -15.73 | -18.15 | -6.46 | -0.54 | -0.53 |
| Interest Expense | -0.05 | -0.02 | -0.35 | -0.62 | -0.17 | -0.05 |
| Interest & Investment Income | 0.12 | 0.17 | 0.18 | 0 | - | - |
| Other Non Operating Income (Expenses) | -0.06 | - | -0.02 | -0 | -0 | -0 |
| EBT Excluding Unusual Items | -13.72 | -15.58 | -18.34 | -7.08 | -0.71 | -0.59 |
| Legal Settlements | - | - | -0.57 | - | - | - |
| Pretax Income | -13.72 | -15.58 | -18.92 | -7.08 | -0.71 | -0.59 |
| Earnings From Continuing Operations | -13.72 | -15.58 | -18.92 | -7.08 | -0.71 | -0.59 |
| Minority Interest in Earnings | - | - | - | 0.03 | 0.12 | 0.08 |
| Net Income | -13.72 | -15.58 | -18.92 | -7.05 | -0.59 | -0.51 |
| Net Income to Common | -13.72 | -15.58 | -18.92 | -7.05 | -0.59 | -0.51 |
| Shares Outstanding (Basic) | 1 | 0 | 0 | 0 | 0 | 0 |
| Shares Outstanding (Diluted) | 1 | 0 | 0 | 0 | 0 | 0 |
| Shares Change (YoY) | 176.37% | 126.47% | 787.00% | 8.80% | - | - |
| EPS (Basic) | -27.13 | -68.71 | -188.93 | -624.38 | -56.40 | -49.12 |
| EPS (Diluted) | -27.13 | -68.71 | -188.93 | -624.38 | -56.40 | -49.12 |
| Free Cash Flow | -9.69 | -12.54 | -12.87 | -4.39 | -0.17 | -0.24 |
| Free Cash Flow Per Share | -19.17 | -55.32 | -128.56 | -389.26 | -16.13 | -22.67 |
| Gross Margin | 57.83% | 42.38% | -92.76% | 65.63% | 58.34% | 65.96% |
| Operating Margin | -414.30% | -537.12% | -2626.77% | -4038.13% | -1223.85% | -994.49% |
| Profit Margin | -413.88% | -532.14% | -2737.63% | -4405.00% | -1335.41% | -950.00% |
| Free Cash Flow Margin | -292.43% | -428.42% | -1862.81% | -2746.25% | -381.93% | -438.48% |
| EBITDA | -13.35 | -15.53 | -18.07 | -6.46 | - | - |
| D&A For EBITDA | 0.38 | 0.2 | 0.08 | 0 | - | - |
| EBIT | -13.73 | -15.73 | -18.15 | -6.46 | -0.54 | -0.53 |
Source: S&P Capital IQ. Standard template.
Financial Sources.